ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

475
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
bearishCelltrion Inc
07 Sep 2017 10:09

Celltrion Has Potential Manufacturing Headaches

A Form 483 from the USFDA (attached) that criticizes aspects of Celltrion Inc (068270 KS)'s manufacturing facility in Incheon has surfaced in the...

Share
bullishCelltrion Inc
23 Aug 2017 04:03

More Discussions on Impacts of Celltrion's KOSPI200 Inclusion

Celltrion Inc (068270 KS) said in a regulatory filing that it will have EGM at 10 AM on Aug 29 to decide whether it will move to KOSPI. Below is...

Logo
497 Views
Share
bearishCelltrion Inc
10 Aug 2017 19:54

NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move

Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...

Logo
1.4k Views
Share
31 Jul 2017 01:45

Recap on Celltrion Healthcare IPO Day - Retail Investors Turned Positive, Why?

Celltrion Healthcare (091990 KS)'s performance on its market debut day was a bit of a surprise. Of course, given that the IPO price was set at the...

Logo
167 Views
Share
bearishCelltrion Inc
19 Jul 2017 06:14

JNJ's REMICADE Holds: PFE's Results To Confirm

Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...

Share
x